These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Dietary fats and prevention of atheroma in diabetes]. Basdevant A; Guy-Grand B Journ Annu Diabetol Hotel Dieu; 1985; ():255-68. PubMed ID: 2577969 [No Abstract] [Full Text] [Related]
7. PPAR alpha, fibrates, lipid metabolism and inflammation. Duval C; Fruchart JC; Staels B Arch Mal Coeur Vaiss; 2004 Jun; 97(6):665-72. PubMed ID: 15283041 [TBL] [Abstract][Full Text] [Related]
8. [Metabolism of lipids and arteritis]. Warembourg H; Bertrand M Angeiologie; 1967; 20():Suppl:29-37. PubMed ID: 5621505 [No Abstract] [Full Text] [Related]
9. [Good prevention of type 2 diabetes with lipid-lowering statin therapy. Intervention studies support active treatment of risk patients]. Nilsson PM; Attvall S; Båvenholm P Lakartidningen; 2004 Nov; 101(47):3798, 3801-2, 3804. PubMed ID: 15609534 [No Abstract] [Full Text] [Related]
10. Fat and fatty acid intake and metabolic effects in the human body. Sanders TA Ann Nutr Metab; 2009; 55(1-3):162-72. PubMed ID: 19752541 [No Abstract] [Full Text] [Related]
12. [Individualized therapy of fat metabolism disorders. Focusing on total cardiovascular risk]. Fortschr Med Suppl; 1992; 125():1-11. PubMed ID: 1628871 [No Abstract] [Full Text] [Related]
13. Case studies in lipid management. Tallis GA; Popplewell PY; Phillips PJ Aust Fam Physician; 1995 Sep; 24(9):1627-31, 1634-5, 1637. PubMed ID: 7487648 [TBL] [Abstract][Full Text] [Related]
14. [The significance of disorders of carbohydrate and lipid metabolism for the development of degenerative cardiovascular diseases]. Z Gesamte Inn Med; 1976 Feb; 31(4):337-40. PubMed ID: 948919 [No Abstract] [Full Text] [Related]
15. Drug insight: the role of statins in combination with ezetimibe to lower LDL cholesterol. Gotto AM; Farmer JA Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):664-72. PubMed ID: 17122799 [TBL] [Abstract][Full Text] [Related]
16. [Treatment with statins for the reduction of cardiovascular risk]. Chiariello M Ital Heart J Suppl; 2001 Mar; 2(3):221-3. PubMed ID: 11307779 [No Abstract] [Full Text] [Related]
17. [HDL-cholesterol: role of its dosage in the assessment of cardiovascular risk]. Guinchard-Foulon E; Rodriguez-Lafrasse C; Rousson R Ann Biol Clin (Paris); 2003; 61(5):549-56. PubMed ID: 14671752 [TBL] [Abstract][Full Text] [Related]
18. [Good fats, bad fats]. von Grätz PG Dtsch Med Wochenschr; 2006 Oct; Suppl 1():38-9. PubMed ID: 17598251 [No Abstract] [Full Text] [Related]
19. More about cardiovascular disease and lipid management in New Zealand. Metcalfe S; Moodie P N Z Med J; 2002 Oct; 115(1163):U203. PubMed ID: 12552309 [No Abstract] [Full Text] [Related]